Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation
-
December 16, 2020
J&J Elmiron Suits Sent To NJ Federal Court
The Judicial Panel on Multidistrict Litigation on Tuesday sent suits alleging Johnson & Johnson's pharmaceutical unit concealed a harmful side effect of bladder cyst medicine that results in serious eye damage to New Jersey federal court, where a judge has already taken steps to organize the litigation.
-
September 25, 2020
NJ's The Place For Eye Damage MDL, Patients Say
Lawsuits alleging Johnson & Johnson's pharmaceutical unit concealed a harmful side effect of bladder cyst medicine Elmiron should be heard in New Jersey federal court due to the number of cases already filed there, a group of patients told the Judicial Panel on Multidistrict Litigation Friday.